"i believe they are working on a new catheter as we speak" that sounds expensive.. Have they the bandwidth for that type of approach? Do we have any public references where they have mentioned this?
So much of perceived value is in patents and protections for innovation.
Does anyone have execution risk factored into their models with the succession of the technology internally?? or from competitors?
IMR Price at posting:
53.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)